Reduced Intensity Total Body Irradiation + Thymoglobulin Followed by Allogeneic PBSCT
Status:
Completed
Trial end date:
2017-06-28
Target enrollment:
Participant gender:
Summary
One of two different doses of thymoglobulin will allow bone marrow engraftment with minimal
Graft-versus-Host Disease and allow adequate immune response to allow the transplanted stem
cells to replace the tumor cells.